Darvocet-N 100

Chronic Pain
Treatment
2 FDA approvals
20 Active Studies for Darvocet-N 100

What is Darvocet-N 100

DextropropoxypheneThe Generic name of this drug
Treatment SummaryAcetaminophen, also known as Tylenol, is a widely used medication to relieve pain and reduce fever. It comes in many forms such as syrup, tablets, injection, and suppositories. Acetaminophen is also a common ingredient in many over-the-counter medications. It is important to follow the recommended dose guidelines when taking acetaminophen, as taking too much can lead to serious side effects such as liver failure and even death.
Propoxypheneis the brand name
image of different drug pills on a surface
Darvocet-N 100 Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Propoxyphene
Dextropropoxyphene
1973
64

Approved as Treatment by the FDA

Dextropropoxyphene, also known as Propoxyphene, is approved by the FDA for 2 uses like Chronic Pain and Pain .
Chronic Pain
Helps manage Pain
Pain
Helps manage Pain

Effectiveness

How Darvocet-N 100 Affects PatientsAcetaminophen has been shown to reduce fever and relieve pain, but unlike other medicines in the same class, it does not have anti-inflammatory effects. It is also unlikely to cause allergic reactions. Acetaminophen does not affect the body's acid-base balance, disrupt tubular secretion of uric acid, or inhibit platelet aggregation when taken at the recommended doses.
How Darvocet-N 100 works in the bodyWe don't know exactly how acetaminophen works, but it's thought to increase the pain threshold by stopping two enzymes from producing molecules that cause pain. These enzymes are found in the brain and have no effect on other parts of the body. Acetaminophen also affects other brain centers which help regulate body temperature, which is why it can be used to reduce fever. More research is needed to understand acetaminophen's full mechanism of action.

When to interrupt dosage

The prescribed measure of Darvocet-N 100 is contingent upon the designated affliction, including Pain, Spasm and Inflammation. The amount of dosage is determined by the technique of delivery as detailed in the table beneath.
Condition
Dosage
Administration
Chronic Pain
, 65.0 mg, 100.0 mg, 50.0 mg
, Oral, Tablet, film coated, Tablet, film coated - Oral, Capsule, Capsule - Oral, Tablet - Oral, Tablet

Warnings

Darvocet-N 100 Contraindications
Condition
Risk Level
Notes
Hypercarbia
Do Not Combine
Asthma
Do Not Combine
Mental Depression
Do Not Combine
Intestinal Pseudo-Obstruction
Do Not Combine
Asthma
Do Not Combine
There are 20 known major drug interactions with Darvocet-N 100.
Common Darvocet-N 100 Drug Interactions
Drug Name
Risk Level
Description
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
Major
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Dextropropoxyphene.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Dextropropoxyphene.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Dextropropoxyphene.
Alpelisib
Major
The metabolism of Alpelisib can be decreased when combined with Dextropropoxyphene.
Darvocet-N 100 Toxicity & Overdose RiskAcetaminophen is toxic at high doses in rats and mice, and can cause symptoms such as kidney damage, low blood sugar, low platelets, and liver failure. In rare cases, long-term use can lead to cancer in female rats. It is also potentially mutagenic and could disrupt chromosomes. Studies in animals have not shown any effects on fertility, but human studies are not available. During pregnancy, acetaminophen should only be used when necessary. Small amounts of the drug are found in breastmilk, so it should be used cautiously while nursing.
image of a doctor in a lab doing drug, clinical research

Darvocet-N 100 Novel Uses: Which Conditions Have a Clinical Trial Featuring Darvocet-N 100?

698 active trials are currently underway to assess the potential of Darvocet-N 100 in alleviating Chronic Pain, Rheumatoid Arthritis and Allergies.
Condition
Clinical Trials
Trial Phases
Chronic Pain
130 Actively Recruiting
Not Applicable, Phase 4, Phase 2, Phase 3, Early Phase 1, Phase 1

Darvocet-N 100 Reviews: What are patients saying about Darvocet-N 100?

5Patient Review
12/3/2012
Darvocet-N 100 for Pain
I'm allergic to Codiene, but this Darvocet-N 100 helps me a lot with pain management. It's the only medication that doesn't make me nauseous or cause abdominal discomfort.
5Patient Review
3/9/2013
Darvocet-N 100 for Pain
This is by far the best pain medication I've ever taken. With other drugs, I often experience bad rashes and itching, but that's not been an issue with this one.
5Patient Review
1/18/2013
Darvocet-N 100 for Pain
This treatment has helped me immensely. I can now walk and live a normal life again.
5Patient Review
7/2/2014
Darvocet-N 100 for Pain
This was the only pain medication that put a dent in my agony during an infected wisdom tooth issue. Only on it a short time.
5Patient Review
1/31/2013
Darvocet-N 100 for Pain
I never felt like I was overmedicated.
5Patient Review
3/15/2012
Darvocet-N 100 for Pain
5Patient Review
5/19/2012
Darvocet-N 100 for Pain
5Patient Review
6/10/2012
Darvocet-N 100 for Pain
5Patient Review
9/17/2012
Darvocet-N 100 for Pain
5Patient Review
12/29/2012
Darvocet-N 100 for Pain
This was really effective for me and I hope there's something similar on the market now.
5Patient Review
2/19/2014
Darvocet-N 100 for Pain
This was the only thing that really worked for my pain. My doctor said it was stupid for FDA to ban it.
4.7Patient Review
6/8/2012
Darvocet-N 100 for Pain
4Patient Review
6/19/2012
Darvocet-N 100 for Pain
3.7Patient Review
11/18/2013
Darvocet-N 100 for Pain
I got great results from this treatment, but I'm wondering if it's safe for me to take if I have high blood pressure.
3Patient Review
6/2/2014
Darvocet-N 100 for Pain
The only pain medication I can use without experiencing any negative side effects.
1.3Patient Review
2/12/2013
Darvocet-N 100 for Pain
I have terrible arthritis and fibromylgia. This was the best pain med I ever took. It completely relieved my pain and allowed me to live a normal life again.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about darvocet-n 100

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are Darvocet still on the market?

"The FDA has concluded that the risks associated with propoxyphene outweigh the benefits and as a result, all propoxyphene-containing products (including Darvocet and Darvon) are no longer available."

Answered by AI

Why was Darvocet-N taken off the market?

"After a study found that the drugs put patients at risk of arrhythmias, or heart rhythm abnormalities, the FDA decided that the risks of the drugs were greater than their benefits to patients suffering from mild to moderate pain, so the drugs were withdrawn from the market."

Answered by AI

Do they still make Darvocet-N 100?

"Darvocet-N is a mix of a narcotic painkiller and a less strong painkiller, as well as a fever reducer. It is used to treat mild to moderate pain. The Darvocet-N brand is not available in the United States anymore, but there may be generic versions."

Answered by AI

What is Darvocet-N 100 used for?

"Darvocet-N, which contains propoxyphene napsylate and acetaminophen, is used to relieve mild to moderate pain. Because it is a strong opioid pain medicine that can be abused by people who abuse prescription medicines or street drugs, it is a federally controlled substance (C-IV)."

Answered by AI

Clinical Trials for Darvocet-N 100

Image of Vanderbilt University Medical Center in Nashville, United States.

Lidocaine Infusions for Postoperative Pain

18+
All Sexes
Nashville, TN
The goal of this single-center, pragmatic, randomized, blinded, placebo-controlled trial is to evaluate the impact of intravenous (IV) lidocaine within the existing Enhanced Recovery After Surgery (ERAS)program on outcomes in patients after major abdominal surgery. The main questions the trial aims to answer are: The primary hypothesis is that utilization of IV lidocaine as part of a perioperative multimodal pain regimen will result in a reduction in hospital Case Mix Index-Adjusted Resource Length of Stay (CARLOS). The secondary hypotheses are that lidocaine infusion will result in a reduction in total inpatient opioid consumption (oral morphine milligram equivalents, oMMEs) and pain scores, and improved surgical outcomes (including return of bowel function, ileus, nausea, rapid responses called, surgical site infections, and ICU transfers), while also having minimal incidence of side effects (including double/blurry vision, tinnitus, sedation, and adverse events requiring early cessation).
Phase 4
Waitlist Available
Vanderbilt University Medical CenterDanial Shams, MD
Have you considered Darvocet-N 100 clinical trials? We made a collection of clinical trials featuring Darvocet-N 100, we think they might fit your search criteria.Go to Trials
Image of University Hospitals Cleveland Medical Center in Cleveland, United States.

Erector Spinae Plane Block for Pain

21 - 75
All Sexes
Cleveland, OH
As per usual care for spine surgery, participants will have their back cleaned with alcohol and a needle will be placed using ultrasound for the ESP block. Through the needle, a small catheter will be placed in the participants back and the needle removed. Approximately one hour prior to the start of surgery, a numbing medication (ropivacaine, similar to Novocaine) in combination with dexmedetomidine (a pain medicine that is used in nerve block and that is not a narcotic) and contrast dye (iohexol) will be injected through the catheter. Participants will then go through the QST procedure (test of buzzing sensation and temperature sensation through pads applied to their skin) to assess the numb areas and then head to the operating room. In the operating room, the catheter will be removed after the surgeon obtains baseline CT scan images of the spine. Once surgery is completed, investigators will record pain scores over the next four days in the hospital and the amount of pain medication needed for controlling pain related to the surgery.
Recruiting
Has No Placebo
University Hospitals Cleveland Medical CenterSalim Hayek, MD
Have you considered Darvocet-N 100 clinical trials? We made a collection of clinical trials featuring Darvocet-N 100, we think they might fit your search criteria.Go to Trials
Image of BC Children's Hospital in Vancouver, Canada.

Digital Media for Anxiety in Children

5 - 23
All Sexes
Vancouver, Canada
The goal of this clinical trial is to learn whether different forms of media (2D, 360, or 360 in virtual reality) have different impacts on pre-procedural anxiety and post-procedural pain in children. The main questions it aims to answer are: Does one type (and richness) of media reduce pre-procedural anxiety and post-procedural pain more than another type of media? For example, will learning about an upcoming procedure by watching a 360 video in virtual reality reduce pre-procedural anxiety more than learning about the same upcoming procedure by watching it in a 2D video or 360 video? The second question is whether watching a 360 video in VR about an upcoming procedure more effective in reducing pre-procedural anxiety and post-procedural pain compared to the 2D video or the 360 video without VR groups for specific procedures? For example, is watching an explanation of a procedure in VR always more effective in reducing pre-procedural anxiety and post-procedural pain, or is it procedure specific (i.e., watching a video about surgery preparation is more effective in VR, but for cast removal it doesn't matter whether participants learn about their procedure viewed through VR, 360 video, or 2D)?
Recruiting
Has No Placebo
BC Children's Hospital
Image of Active Aging Research Team, Robert H. N. Ho Research Centre in Vancouver, Canada.

Choose to Move Replacement Ready for Osteoarthritis

18+
All Sexes
Vancouver, Canada
Choose to Move (CTM) is a 3-month, choice-based health-promoting program for low active older adults being scaled-up across British Columbia (BC), Canada. Recently, the investigators adapted CTM for the \>14000 people in BC who are on surgical waitlists for total knee replacement or total hip replacement (TKR/THR) for osteoarthritis (OA). The primary goal of this observational study is to learn if the adapted program, Choose to Move Replacement Ready (CTM-RR), is feasible to deliver to people with hip and/or knee osteoarthritis who are on surgical waitlists for TKR/THR. Participants who enrol in CTM-RR will answer online survey questions about the program and about their physical activity, mobility, pain, function, quality of life, willingness to undergo surgery, overall perception of their joint condition, psychosocial health, self-efficacy, social isolation, loneliness, and sedentary time. CTM-RR activity coaches will also answer online survey questions about the program. CTM-RR participants, activity coaches, and referral partners will also participate in interviews about the program.
Recruiting
Has No Placebo
Active Aging Research Team, Robert H. N. Ho Research CentreHeather A. McKay, PhD
Have you considered Darvocet-N 100 clinical trials? We made a collection of clinical trials featuring Darvocet-N 100, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security